Entellus Medical, Inc. (NASDAQ: ENTL) today announced data from its first-in-human study of the Latera® absorbable nasal implant from Spirox® ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Management Comments

Entellus Announces Long-Term Data Confirming the Durable Relief of Nasal Obstruction Symptoms with Latera® from Spirox®October 30, 2017 8:30 AM